Correlation Between Enlivex Therapeutics and Living Cell
Can any of the company-specific risk be diversified away by investing in both Enlivex Therapeutics and Living Cell at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enlivex Therapeutics and Living Cell into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Enlivex Therapeutics and Living Cell Technologies, you can compare the effects of market volatilities on Enlivex Therapeutics and Living Cell and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enlivex Therapeutics with a short position of Living Cell. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enlivex Therapeutics and Living Cell.
Diversification Opportunities for Enlivex Therapeutics and Living Cell
0.19 | Correlation Coefficient |
Average diversification
The 3 months correlation between Enlivex and Living is 0.19. Overlapping area represents the amount of risk that can be diversified away by holding Enlivex Therapeutics and Living Cell Technologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Living Cell Technologies and Enlivex Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enlivex Therapeutics are associated (or correlated) with Living Cell. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Living Cell Technologies has no effect on the direction of Enlivex Therapeutics i.e., Enlivex Therapeutics and Living Cell go up and down completely randomly.
Pair Corralation between Enlivex Therapeutics and Living Cell
Given the investment horizon of 90 days Enlivex Therapeutics is expected to generate 0.57 times more return on investment than Living Cell. However, Enlivex Therapeutics is 1.76 times less risky than Living Cell. It trades about -0.05 of its potential returns per unit of risk. Living Cell Technologies is currently generating about -0.04 per unit of risk. If you would invest 159.00 in Enlivex Therapeutics on September 12, 2024 and sell it today you would lose (34.00) from holding Enlivex Therapeutics or give up 21.38% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Enlivex Therapeutics vs. Living Cell Technologies
Performance |
Timeline |
Enlivex Therapeutics |
Living Cell Technologies |
Enlivex Therapeutics and Living Cell Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Enlivex Therapeutics and Living Cell
The main advantage of trading using opposite Enlivex Therapeutics and Living Cell positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enlivex Therapeutics position performs unexpectedly, Living Cell can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Living Cell will offset losses from the drop in Living Cell's long position.Enlivex Therapeutics vs. Pluri Inc | Enlivex Therapeutics vs. BioLineRx | Enlivex Therapeutics vs. Purple Biotech | Enlivex Therapeutics vs. Histogen |
Living Cell vs. Sino Biopharmaceutical Ltd | Living Cell vs. Defence Therapeutics | Living Cell vs. Aileron Therapeutics | Living Cell vs. Enlivex Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Complementary Tools
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |